- Tags: retina
Research
NSAID use may lower AMD risk
Prescribed patients appear less likely for disease development, with the association observed across multiple AMD subtypes and several commonly used medications
Pipeline
4DMT reports new phase 2b gene therapy data for wet AMD
New 2-year data demonstrates an overall 78% treatment reduction in patients treated with 4D-150 compared to bimonthly 2 mg aflibercept.
Pipeline
Belite Bio presents updated phase 3 data on oral tinlarebant for Stargardt
Findings released at ASRS highlight an 80% reduction in key protein implicated in Stargardt disease after 2 years.
Products
EVOQ Technologies receives US patent for mobile retinal function testing
Patent protection covers the SmartERG, a full-field ERG/VEP system that delivers visual stimulation and wirelessly records ocular electrophysiological responses.
Products
FDA approves Outlook's LYTENAVA for wet AMD
The VEGF inhibitor is now the first and only on-label ophthalmic formulation of bevacizumab for wet AMD treatment.
Research
Real-world pegcetacoplan data shows VA benefits through 18 months
EHR and AI-based imaging analysis presented at ASRS demonstrates SYFOVRE advantages extending to GA patients with concomitant wet AMD.
Research
Mediterranean diet linked to slower AMD progression
Diet aherence associated with slower AMD progression at every disease stage, with specific food components mattering most depending on the stage.
Events
ASRS 2026: industry highlights and product innovations
Annual retina specialists meeting kicks off in Montreal with immersive, interactive experiences and technology showcases.
Events
ASRS 2026: your retina research rundown
Annual meeting of retina specialists kicks off in Montreal with updates on the latest clinical findings shaping the future of retina research.
Business
Tarsus acquires iRenix Medical, adds late-stage ocular antiseptic
Company to initiate a phase 3 trial on IRX-101, an ocular antiseptic alternative to povidone-iodine among retinal patients receiving IVT injections.
Products
Eyes On Eyecare launches retina research-based app
Cited for Retina offers a “PubMed meets Instagram Stories” way for retina specialists to discover, digest, and react to new research shaping their practice.
Pipeline
RegenxBio doses first patient in phase 2b/3 trial for DR
One-time gene therapy continues to move down the pipeline, with presentations on efficacy and safety data expected at ASRS.
Research
Leukemia may appear in RVO prior to diagnosis
Ocular findings linked to leukemia may emerge before systemic symptoms, with retinal vascular changes sometimes serving as an early clinical clue.
Research
Study identifies stroke risks following ischemic ocular events
Nearly one in four patients had a stroke or transient ischemic attack within a year.
Products
Lumibird Medical launches wireless IntegreLIO system
First truly wireless integrated LIO enables unrestricted freedom of movement for physicians performing PRP and other peripheral retinal treatments.
Research
White blood cell counts higher among CRAO patients
Higher systemic leukocyte and lymphocyte levels point to subtype-specific inflammatory profiles.
Pipeline
Alkeus begins dosing in global phase 3 Stargardt trial on oral gildeuretinol
Phase 3 NORTHSTAR study seeks to build on growing evidence that ALK-001 benefits low luminance visual acuity.
Products
FDA approves Lupin's Lucentis biosimilar injection
Ranluspec (ranibizumab-hkdz) marks the third ranibizumab biosimilar cleared in the U.S. to treat five retinal indications.
Pipeline
Oculis's phase 3 DME eye drop trial fails primary goals
While OCS-01 was well-tolerated, the DIAMOND program did not meet either outcome measures; company will not seek an FDA NDA filing.
Business